This pilot clinical trial studies transoral robotic surgery (TORS) in treating patients with benign or malignant tumors of the head and neck. TORS is a less invasive type of surgery for head and neck cancer and may have fewer side effects and improve recovery
To conduct a pilot single-arm study to assess transoral robotic surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the Da Vinci Robotic Surgical System.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
600
Undergo TORS using the Da Vinci Robotic Surgical System
After surgery regular clinical assessments will be scheduled to see how the patient is doing. Patients will be asked to answer a quality of life assessment as part of the study. If patients are unable to come to the Ohio State University Medical Center for a physician appointment they will be contacted via phone or mailed a questionnaire to complete.
Ohio State University Medical Center
Columbus, Ohio, United States
RECRUITINGDetermine the feasibility of the TORS in patients with oral and laryngopharyngeal benign and malignant lesions.
Time frame: up to eight years
Assess the impact of TORS on the intra-operative surgical outcomes such as operative time, blood loss and complications.
If the planned procedure is a combined procedure, (robotic + non robotic) above mentioned measures are going to be presented separately for successful fully robotic surgeries and for unsuccessful mixed surgeries. 2\. To identify the learning curve for TORS by measuring the efficiency and accuracy of the surgeons who perform the procedures.
Time frame: up to eight years
Assess the quality of life of the patients with TORS.
Time frame: up to eight years
Ohio State University Comprehensive Cancer Center
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.